Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.

Loading...
Thumbnail Image
Date
2011-07
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Description
Keywords
Choroidal neovascularization, intravitreal injection, ocular toxoplasmosis, ranibizumab, vascular endothelial growth factor
Citation
Shah Nikunj J, Shah Urmi N. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian Journal of Ophthalmology. 2011 July; 59(4): 318-319.